Acervo Científico
Veja nossa seleção de artigos científicos sobre o uso da Cannabis medicinal no tratamento de diversas doenças.
- Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo.
- Cannabidiol modulates the expression of Alzheimer’s disease-related genes in mesenchymal stem cells.
- Cannabidiol reverses deficits in hippocampal LTP in a model of Alzheimer’s disease.
- Chronic cannabidiol treatment improves social and object recognition in double transgenicity.
- Effects of cannabidiol interactions with Wnt B-catenin pathway and PPARy on oxidative stress and neuroinflammation in Alzheimer’s disease.
- In vivo evidence for therapeutic properties of cannabidiol (CBD) for Alzheimer’s disease.
- Long-term cannabidiol treatment prevents the development of social recognition memory deficits in Alzheimer’s disease transgenic mice.
- The brain endocannabinoid system in Alzheimer’s disease.
- The therapeutic potential of the endocannabinoid system for Alzheimer’s disease.
- The therapeutic potential of the phytocannabinoid cannabidiol for Alzheimer’s disease.
- Using CBD (cannabidiol) to treat symptoms of Alzheimer’s and other dementias.
- Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry.
- Evaluation of cannabinoid and terpenoid content – cannabis flowers compared to supercritical CO2 concentrate.
- Evolution of the cannabinoid and terpene content during the growth of Cannabis sativa plants from different chemotypes.
- GC-MS analysis of the total THC content of both drug- and fiber-type cannabis seeds.
- Antidepressant-like and anxiolytic-like effects of cannabidiol.
- Anxiety effect of cannabidiol in the elevated plus-maze.
- Canabidiol, um componente da Cannabis sativa, como um ansiolítico.
- Cannabidiol as a potential treatment for anxiety disorders.
- Cannabidiol reduces anxiety-related behavior in mice via an FMRP.
- Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients.
- Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1a receptor-mediated suppresion of nause and anxiety in rats.
- Cannabis and anxiety – a critical review of the evidence.
- Cannabis and the anxiety of fragmentation – a systems approach for finding an anxiolytic cannabis chemotype.
- CBD regulation of emotion and emotional memory processing – relevance for treating anxiety-related and substance abuse disorders.
- Effectiveness of cannabidiol oil for pediatric anxiety and insomnia as part of posttraumatic stress disorder.
- Neural basis of anxiolytic effects of cannabidiol in generalized social anxiety disorder.
- Targeting the endocannabinoid system to treat anxiety-related disorders.
- The endocannabinoid system and anxiety.
- The endocannabinoid system as a target for novel anxiolytic drugs.
- Antidepressant-like and anxiolytic-like effects of cannabidiol.
- Antidepressant-like effect induced by cannabidiol is dependent on brain serotonin levels.
- Antidepressant-like effect of THC and other cannabinoids isolated from Cannabis sativa.
- Antidepressant-like effects of CBD in mice – possible involvment of 5-HT1A receptors.
- Antidepressant-like effects of CBD injection into the ventral medial prefrontal cortex.
- CBD induces rapid and sustained antidepressant-like effects through increased BDNF signaling and synaptogenesis in the prefrontal cortex.
- CBD induces rapid-acting antidepressant effects and enhances cortical 5-HT-glutamate neurotransmission – role of 5HT1A receptors.
- CBD induces rapid-acting antidepressant-like effects and enhances cortical 5-HT and glutamate neurotransmission.
- Efeitos da administração de CBD e Imipramina no teste do nado forçado e nos níveis de BDNF de ratos.
- Emerging evidence for the antidepressant effect of CBD and the underlying molecular mechanisms.
- Prohedonic effect of CBD in a rat model of depression.
- Anti-inflammatory activity in colon models is derived from THCA that interacts with addition compounds in cannabis extracts.
- Anti-inflammatory and antioxidant effects of a combination of cannabinoid and moringin in LPS-stimulated macrophages.
- Cannabinoids, inflammation and fibrosis.
- Cannabis and pediatric inflammatory bowel disease – change blossoms a mile high.
- Cannabis, a potential treatment option in pediatric IBD – still a long way to go.
- Cannabisnoids for treating inflammatory bowel diseases – where are we and where do we go.
- CBD and its analogs – a review of their effects on inflammation.
- CBD in inflammatory bowel diseases – a brief overview.
- Endocannabinoids in arthritis – current views and perspective.
- HU-444, a novel potent anti-inflammatory nonpscyhotropic cannabinoid.
- Manipulation of the endocannabinoid system in colitis – a comprehensive review.
- Role of cannabinoids in gastrointestinal mucosal defense and inflammation.
- The anti-inflammatory properties of terpenoids from cannabis.
- The nonpsychoactive cannabis constituent CBD is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
- The nonpsychoative cannabis constituent CBD is an oral anti-arthritic therapeutic in murine collagen-induced arthritis.
- Therapeutic use of cannabis in inflammatory bowel disease.
- Anti-inflammatory and antioxidant effects of a combination of cannabinoid and moringin in LPS-stimulated macrophages.
- Cannabidiol attenuates OGDR-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose.
- Effects of CBD on amphetamine-induced osidative stress generation in an animal model of mania.
- Understanding the molecular aspects of THC and CBD as antioxidants.
- Anti-aversive effects of CBD on innate fear-induced behaviors evoked by an ethological model of panic attacks based on a Prey vs the Wild Snake Epicrates cenchria crassus controntation paradigm.
- Evidences for the anti-panic actions of cannabidiol.
- Involvement of serotonin-mediated neurotransmission in the dorsal periaqueductal gray matter on CBD chronic effects in panic-like responses in rats.
- The role of 5HT1A receptors in the anti-aversive effects of CBD on panic attack-like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus.
- CBD as a potential new type of an antipsychotic. A critical review of the evidence.
- CBD, a Cannabis sativa constituent, as an antipsychotic drug.
- Decreased glial reactivity could be involved in the antipsychotic-like effect of CBD.
- Probing the endocannabinoid system in healthy volunteers – CBD alters fronto-striatal resting-state connectivity.
- The potential of CBD treatment for cannabis users with recent-onset psychosis.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise usteer está la cosa muy malar.
Conteúdo da alternância
Conteúdo da alternância
Conteúdo da alternância
Conteúdo da alternância
Conteúdo da alternância
- Canabidiol reduz crises atônicas na síndrome de Lennox-Gastaut.
- Cannabidiol – pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
- Cannabis and epilepsy – from recreational abuse to therapeutic use.
- CBD-enriched medical cannabis for intractable pediatric epilepsy. The current Israeli experience.
- Effect of CBD on drop seizures in the Lennox-Gastaut syndrome.
- Epilepsia – protocolo clínico e diretrizes terapêuticas.
- Epilepsy and cannabis – a literature review.
- Epilepsy and marijuana.
- Epilepsy and memory.
- Marijuana and epilepsy – neuroscience fundamentals.
- Marijuana compound curbs seizures by pushing brakes in brain.
- Marijuana use and the risk of new onset seizures.
- O uso do CBD no tratamento da epilepsia.
- Pharmacotherapeytic and non-pharmacological options for refractory and difficult-to-treat seizures.
- Phytocannabinoids and epilepsy.
- Potential clinical benefits of CBD-rich cannabis extracts over purified CBD in treatment-resistant epilepsy.
- Proposta de acompanhamento clínico farmacêutico do tratamento de epilepsia refratária com extratos de cannabis.
- Report of a parent survey of CBD-enriched cannabis use in pediatric treatment-resistant epilepsy.
- Single and synergistic effects of cannabidiol and D9-tetrahydrocannabinol on zebrafish models of neuro-hyperactivity.
- Slim evidence for cannabinoids for epilepsy.
- Synthesis of CBD stereoisomers and analogs as potential anticonvulsant agents.
- THCV supresses in vitro epileptiform and in vivo seizure activity in adult rats.
- The case for assessing CBD in epilepsy.
- The case for medical marijuana in epilepsy.
- The pharmacological basis of cannabis therapy for epilepsy.
- Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome.
- TRPV1 channel – a potential drug target for treating epilepsy.
- Use of CBD in the treatment of epilepsy – efficacy and security in clinical trials.
Conteúdo da alternância
Conteúdo da alternância
Conteúdo da alternância
- A runners high depends on cannabinoid receptors in mice.
- Cannabidiol, a major non-psychotrophic cannabis constituent enhances fracture healing and stimulates lysyl hydroxylase activity in osteoblasts.
- Cannabis – exercise performance and sport – a systematic review.
- Cannabis and exercise science – a commentary on existing studies and suggestions for future directions.
- Cannabis and the health and performance of the elite athlete.
- Cannabis in sport – anti-doping perspective.
- Cannabis use in persons with traumatic spinal cord injury in Denmark.
- Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat diet-induced obesity.
- Effects of exercise stress on the endocannabinoid system in humans under field conditions.
- Endocannabinoids, exercise, pain and a path to health with aging.
- Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus.
- Exercise-induced endocannabinoid signaling is modulated by intensity.
- History of cannabis use is associated with altered gait.
- Intense exercise increases circulating endocannabinoid and BDNF levels in humans – possible implications for reward and depression.
- Intense exercise increases circulating endocannabinoid and BDNF levels in humans – possible implications for reward and depression.
- Marijuana and its effects on athletic performance.
- Prevalence and correlates of cannabis use among athletes.
- Restricted vs. unrestricted wheel running in mice – effects on brain, behavior and endocannabinoids.
- The effect of cannabis on regular cannabis consumers_ ability to ride a bicycle.
Conteúdo da alternância